New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Welltower Inc.

WELL

Real Estate Reit Healthcare Facilities

Welltower Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.8 billion, up 35.6% from fiscal 2024.

Revenue
+38.4%
EPS
+31.7%
Free cash flow
+20.4%
Total debt
+13.9%

Quarter to September 2026, against a year earlier

240.34 2.85 −1.17%

After hours trading: 240.34, unchanged, last trade 4:04pm Eastern.

Market cap
$178.4B
P/E
102×
Fwd P/E FY26e
n/m
Dividend yield
1.32%
F-score
6/9
ROIC
0.59%
Net debt / EBITDA
5.7×
Payout ratio
1.4×

Welltower Inc. (WELL) valuation and DCF model

What the price implies · reverse DCF

At $240.34 the price implies FFO a share growing 23.1% a year for ten years.

FFO a share grew −4.4% a year over the last ten years, −0.5% over the last five. The price asks for 27.5 points a year more than its ten-year rate. The industry’s median company is priced for 4.6%.

In December 2017 the price assumed 3.6% a year; Welltower Inc. went on to grow FFO a share −2.9% a year to FY2025.

FFO a share is worked out from Welltower Inc.’s 10-Ks and 10-Qs: net income, plus the depreciation of its property and impairments, less gains on property sales.

The last twelve months include the quarter to December 2025, when FFO a share was −$0.90 against a median of $1.14 in its other recent quarters; the headline reads the price through all four.

Price implies
23.1%
Last 5 years, reported
−0.5%
Last 10 years, reported
−4.4%
Industry median implies
4.6%

The headline discounts the last twelve months’ FFO a share at 9.0% for ten years and grows it 2.5% a year after that, the same for every company, so the figure compares across the market (how a reverse DCF works).

The other way round · DCF
The price needs
23.1% a year for ten years
$240.34
today’s price
Its base case
−4.4% a year for five years, then −2.6%
$32.29
86.6% below today’s price

Both are growth in FFO a share, discounted at 9.0%, with 2.5% a year after year ten.

Base case on its own ten-year record Welltower Inc.’s own growth, carried forward

Its assumptions

Powerpack lets you start from a scenario and type over any of them.

The base case’s inputs, which Powerpack lets you change
1 · FFO a share
the four quarters to September 2026, from the 10-Q and 10-K filings

Yearly growth in FFO a share. It usually slows as the company matures.

Today’s price implies FFO a share growing 23.1% a year for ten years.

2 · Rates

Cost of equity is the yearly return shareholders require, typically 8–11%. Terminal growth is growth forever after year 10, usually near long-run inflation, 2–3%.

3 · Per share

The model is a share’s own: no debt to take off and no shares to divide among.

Advanced inputs

Against Welltower Inc.’s own cost of capital: risk-free 4.3% + beta 0.75 × equity premium 4.5% = 7.7% cost of equity; weighted, 7.7%.

Use 7.7%
Base case value per share $32.29 ten years discounted, and what follows
Current price $240.34 market price per share
Below today’s price 86.6% downside at the base case’s assumptions

How we got there$17.20 10 years of FFO+$15.09 terminal value=$32.29 per share

Valuation against its own history

Today’s multiple against its 5- and 10-year averages and the industry median (Reit Healthcare Facilities).

Multiple Current 5Y avg 10Y avg vs 10Y avg Industry median vs industry 10Y range
P/E 101.84× 132.17× 90.93× 12% above 24.33× 319% above
P/FCF 18.56× 94.75× 63.68× 71% below 21.43× 13% below
P/B 3.51× 2.40× 2.09× 68% above 1.60× 120% above
EV/EBITDA 57.39× 38.09× 29.92× 92% above 14.75× 289% above
EV/Sales 13.84× 10.84× 9.88× 40% above 7.80× 77% above
P/FFO 74.09× 46.33× 34.77× 113% above — —
20.49×31.85×43.21×54.57×10Y avg 29.92×2017201820192020202120222023202420252026

WELL trades at 57.39× EV/EBITDA, against a 10-year average of 29.92× (range 18.52×–57.39×). That is dearer than 100% of the last 9 year-end readings; re-rating to the average implies $114.22 per share.

Every growth rate on this page is the business’s — its cash flow, FFO or dividend — never its share price’s. A discounted-cash-flow model is only as good as its assumptions. Figures from the 10-K and 10-Q filings. Not investment advice.